Classes
DEA Class; Rx
Common Brand Names; Paremyd
- Cycloplegics/Mydriatics
Description
Topical ophthalmic combination of an adrenergic agent and an anticholinergic agent
Used for mydriasis in routine diagnostic procedures and in conditions where short-term pupil dilation desired
Provides diminished pupil responsiveness to light, facilitating ophthalmoscopy
Indications
Indicated for mydriasis induction in routine diagnostic procedures and conditions where short-term pupil dilation is desired.
Contraindications
Hypersensitivity to product components
Known or suspected angle-closure glaucoma, presence of a shallow anterior chamber unless gonioscopic observation of the chamber angle is possible; presence of narrow angle where pupil dilation may precipitate angle-closure glaucoma
Adverse Effects
- Tachycardia
- Pallor
- Headache
- Parasympathetic stimulation
- Transient stinging
- Dry mouth
- Nausea
- Vomiting
- Allergic reactions
- Blurred vision
- Photophobia with or without corneal staining
- Increased IOP
- Muscle rigidity
Warnings
Monitor patients with cardiac disorders, diabetes mellitus, hypertension or hyperthyroidism
May cause increased intraocular pressure (use with caution in patients with glaucoma)
Possibility of undiagnosed glaucoma should be considered
The elderly may experience intraocular pressure increase following use; use caution
Pregnancy and Lactation
Pregnancy Category: C
Lactation: Unknown if excreted in breast milk, use caution
Maximum Dosage
2 drops/procedure per affected eye.
2 drops/procedure per affected eye.
Safety and efficacy have not been established.
Safety and efficacy have not been established.
Safety and efficacy have not been established.
Safety and efficacy have not been established.
How supplied
Hydroxyamphetamine hydrobromide/Tropicamide
ophthalmic solution
- 1%/0.25%
